Clinical Trial Update: A Phase III Trial to Assess the Safety and Efficacy of Plant Cell Expressed GCD in Patients With Gaucher Disease [Phase 3]

View source ↗

Summary

Phase III trial evaluating plant cell expressed GCD for Gaucher disease has completed with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gaucher Disease

Drugs mentioned

• Plant Cell Expressed GCD

Snippet

Sponsor: Pfizer | Conditions: Gaucher Disease | Phase 3 | Status: COMPLETED | Results posted: 2012-07-26